Compare ARVN & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | IVR |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 625.3M |
| IPO Year | 2018 | N/A |
| Metric | ARVN | IVR |
|---|---|---|
| Price | $13.49 | $8.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $15.57 | $8.25 |
| AVG Volume (30 Days) | 743.8K | ★ 2.4M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.08% |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $150.63 |
| Revenue Next Year | $1.94 | N/A |
| P/E Ratio | ★ N/A | $6.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $5.86 |
| 52 Week High | $18.93 | $9.50 |
| Indicator | ARVN | IVR |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 38.69 |
| Support Level | $11.10 | $8.15 |
| Resistance Level | $13.97 | $8.40 |
| Average True Range (ATR) | 0.83 | 0.19 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 81.83 | 20.50 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.